AKEBIA THERAPEUTICS INC (AKBA) Institutional Ownership Changes & 13F Activity

AKEBIA THERAPEUTICS INC (AKBA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Aqr Capital Management Llc, Jacobs Levy Equity Management, Inc, Bank Of America Corp, Two Sigma Investments, Lp, and Millennium Management Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Manufacturers Life Insurance Company, TheBuy+2,919+4.2%71,892$81.96KQ2 2026Sep 09, 2026
Parkside Financial Bank & TrustBuy+465465$524.00Q2 2026Sep 04, 2026
Citadel Advisors LlcBuy+327,592+23.6%1,717,659$1.96MQ2 2026Sep 02, 2026
California State Teachers Retirement SystemSell-10,157-74.1%3,547$4.04KQ2 2026Aug 24, 2026
Mercer Global Advisors IncBuy+100,064+855.8%111,756$127.40KQ2 2026Aug 19, 2026
Public Employees Retirement System Of OhioBuy+294,900294,900$336.19KQ2 2026Aug 17, 2026
Proficio Capital Partners LlcBuy+12,72512,725$14.51KQ2 2026Aug 17, 2026
Aqr Capital Management LlcBuy+7,358,904+410.5%9,151,524$10.43MQ2 2026Aug 14, 2026
Jacobs Levy Equity Management, IncBuy+3,843,357+894.5%4,273,026$4.87MQ2 2026Aug 14, 2026
Bank Of America CorpSell-2,304,612-83.4%458,750$522.98KQ2 2026Aug 14, 2026
Two Sigma Investments, LpBuy+1,138,872+87.8%2,436,673$2.78MQ2 2026Aug 14, 2026
Millennium Management LlcBuy+811,892+34.0%3,196,605$3.64MQ2 2026Aug 14, 2026
Invesco Ltd.Buy+694,928694,928$792.22KQ2 2026Aug 14, 2026
Ameriprise Financial IncBuy+626,160626,160$713.82KQ2 2026Aug 14, 2026
Qube Research & Technologies LtdSell-615,508-25.7%1,779,707$2.03MQ2 2026Aug 14, 2026
Wellington Management Group LlpSell-536,790-75.8%170,955$194.89KQ2 2026Aug 14, 2026
Eversept Partners, LpBuy+427,095427,095$486.89KQ2 2026Aug 14, 2026
Squarepoint Ops LlcSell-363,401-85.9%59,427$67.75KQ2 2026Aug 14, 2026
Mangrove Partners Im, LlcBuy+291,000+77.4%666,954$760.33KQ2 2026Aug 14, 2026
Charles Schwab Investment Management IncBuy+284,861+14.1%2,300,438$2.62MQ2 2026Aug 14, 2026
Wells Fargo & Company/MnBuy+138,423+140.5%236,916$270.08KQ2 2026Aug 14, 2026
Susquehanna International Group, LlpSell-132,298-18.3%589,821$672.40KQ2 2026Aug 14, 2026
Hsbc Holdings PlcSell-124,415-84.0%23,677$26.87KQ2 2026Aug 14, 2026
Alliancebernstein L.P.Buy+115,980+48.5%354,910$493.32KQ2 2026Aug 14, 2026
Cerity Partners LlcBuy+112,117112,117$127.82KQ2 2026Aug 14, 2026
Man Group PlcSell-102,458-39.7%155,396$177.15KQ2 2026Aug 14, 2026
Jain Global LlcBuy+91,41691,416$104.21KQ2 2026Aug 14, 2026
Goldman Sachs Group IncBuy+86,340+2.4%3,689,167$4.21MQ2 2026Aug 14, 2026
D. E. Shaw & Co., Inc.Buy+71,616+444.7%87,722$100.00KQ2 2026Aug 14, 2026
Metlife Investment Management, LlcBuy+60,608+65.7%152,878$174.28KQ2 2026Aug 14, 2026
Showing 30 of 174

Frequently asked questions about AKBA activity

  • Which institutional owners are buying AKBA?

    Institutional owners buying AKBA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in AKBA activity?

    "Buy" means an investor increased their reported position in AKBA compared to the prior reporting period. This reflects growing exposure to AKEBIA THERAPEUTICS INC (AKBA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in AKBA increasing?

    Institutional interest in AKBA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.